USE OF TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF PATIENTS WITH METASTATIC MELANOMA - A PRELIMINARY-REPORT

被引：2103

作者：

ROSENBERG, SA

PACKARD, BS

AEBERSOLD, PM

SOLOMON, D

TOPALIAN, SL

TOY, ST

SIMON, P

LOTZE, MT

YANG, JC

SEIPP, CA

SIMPSON, C

CARTER, C

BOCK, S

SCHWARTZENTRUBER, D

WEI, JP

WHITE, DE

机构：

[1] NCI,PATHOL LAB,BETHESDA,MD 20892

[2] NIH,CTR CLIN,DEPT TRANSFUS MED,BETHESDA,MD 20205

[3] DUPONT CO,GLENOLDEN LABS,WILMINGTON,DE 19898

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1988年 / 319卷 / 25期

关键词：

D O I：

10.1056/NEJM198812223192527

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1676 / 1680

页数：5

共 27 条

[1]

BELLDEGRUN A, 1988, CANCER RES, V48, P206

[2]

BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69

[3]

EBERLEIN TJ, 1982, J EXP MED, V156, P385

[4]

FISHER B, IN PRESS J CLIN ONCO

[5] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS [J].

GRIMM, EA ;

RAMSEY, KM ;

MAZUMDER, A ;

WILSON, DJ ;

DJEU, JY ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :884-897

[6]

ITOH K, 1986, CANCER RES, V46, P3011

[7]

KRADIN RL, 1987, CANCER IMMUNOL IMMUN, V24, P76

[8] FUNCTIONAL-CHARACTERIZATION OF LYMPHOCYTES-T PROPAGATED FROM HUMAN-LUNG CARCINOMAS [J].

KURNICK, JT ;

KRADIN, RL ;

BLUMBERG, R ;

SCHNEEBERGER, EE ;

BOYLE, LA .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 38 (03) :367-380

[9]

LAFRENIERE R, 1985, CANCER RES, V45, P3735

[10] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS [J].

LOTZE, MT ;

CHANG, AE ;

SEIPP, CA ;

SIMPSON, C ;

VETTO, JT ;

ROSENBERG, SA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3117-3124

← 1 2 3 →